iStent with cataract surgery lowers IOP at 8 years in pseudoexfoliation glaucoma

WASHINGTON — Patients with pseudoexfoliation glaucoma treated with iStent plus cataract surgery had sustained IOP reduction at 8 years postop, according to a study.
Tanner J. Ferguson, MD, presented results of the retrospective case review at the American Society of Cataract and Refractive Surgery meeting.
“We’ve previously published this study with results up to 2 years and 5 years,” he said. “This current study represents a continuation out to 8 years postoperatively.”
The study comprised 117 consecutive eyes from patients who underwent implantation of one

WASHINGTON — Patients with pseudoexfoliation glaucoma treated with iStent plus cataract surgery had sustained IOP reduction at 8 years postop, according to a study.
Tanner J. Ferguson, MD, presented results of the retrospective case review at the American Society of Cataract and Refractive Surgery meeting.
“We’ve previously published this study with results up to 2 years and 5 years,” he said. “This current study represents a continuation out to 8 years postoperatively.”
The study comprised 117 consecutive eyes from patients who underwent implantation of one